Consensus $38.4M. Reiterating full year 2025 gross margin guidance of 61% – 63%. Reiterating positive cash flow from operations for full year 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRMD:
- Koru Medical management to meet with Craig-Hallum
- KORU Medical’s CCO Resigns, Interim Leader Appointed
- Repro-Med Systems’ Earnings Call Highlights Growth and Challenges
- REPRO-MED Systems: Strong Financial Performance and Strategic Growth Justify Buy Rating
- KORU Medical Systems Reports Record 2024 Financial Results